{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T05:14:09Z","timestamp":1700284449966},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,11,15]]},"DOI":"10.2169\/internalmedicine.1405-22","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T22:12:51Z","timestamp":1680819171000},"page":"3367-3371","source":"Crossref","is-referenced-by-count":1,"title":["Ceftriaxone-associated Biliary Pseudolithiasis with Elderly Type 1 Diabetes Mellitus: Two Case Reports"],"prefix":"10.2169","volume":"62","author":[{"given":"Ken","family":"Kanazawa","sequence":"first","affiliation":[{"name":"Departments of Diabetes, Metabolism and Endocrinology, Japan Labor Health and Safety Organization, Tokyo Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Departments of Diabetes, Metabolism and Endocrinology, Japan Labor Health and Safety Organization, Tokyo Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Inaba","sequence":"additional","affiliation":[{"name":"Departments of Diabetes, Metabolism and Endocrinology, Japan Labor Health and Safety Organization, Tokyo Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Koga","sequence":"additional","affiliation":[{"name":"Departments of Diabetes, Metabolism and Endocrinology, Japan Labor Health and Safety Organization, Tokyo Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kuwabara","sequence":"additional","affiliation":[{"name":"Departments of Diabetes, Metabolism and Endocrinology, Japan Labor Health and Safety Organization, Tokyo Rosai Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of diabetes in older adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 104: 1520-1574, 2019.","DOI":"10.1210\/jc.2019-00198"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Miller RG, Secrest AM, Sharma RK, et al. Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes 61: 2987-2992, 2012.","DOI":"10.2337\/db11-1625"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther 21: 66-72, 2019.","DOI":"10.1089\/dia.2018.0384"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Palanduz A, Yal\u00e7in I, Tongu\u00e7 E, et al. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound 28: 166-168, 2000.","DOI":"10.1002\/(SICI)1097-0096(200005)28:4<166::AID-JCU2>3.0.CO;2-G"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ozturk A, Kaya M, Zeyrek D, et al. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children. Acta Radiol 46: 112-116, 2005.","DOI":"10.1080\/02841850510015983"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Abe S. A case of ceftriaxone-associated biliary pseudolithiasis in an elderly patient with renal dysfunction. IDCases 9: 62-64, 2017.","DOI":"10.1016\/j.idcr.2017.06.007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sasaki O, Sugimura K, Shinoda M, et al. Asymptomatic ceftriaxone-associated pseudolithiasis. J Gen Fam Med 20: 209-212, 2019.","DOI":"10.1002\/jgf2.269"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Richards DM, Heel RC, Brogden RN, et al. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 27: 469-527, 1984.","DOI":"10.2165\/00003495-198427060-00001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kim S, Gura KM, Puder M. Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis. Pediatr Surg Int 22: 562-564, 2006.","DOI":"10.1007\/s00383-006-1656-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Imafuku A, Sawa N, Sekine A, et al. Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction. Clin Exp Nephrol 22: 613-619, 2018.","DOI":"10.1007\/s10157-017-1493-7"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. de Boer SY, Masclee AA, Lam WF, et al. Effect of hyperglycaemia on gallbladder motility in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 37: 75-81, 1994.","DOI":"10.1007\/BF00428781"},{"key":"12","unstructured":"12. Hahm JS, Park JY, Park KG, et al. Gallbladder motility in diabetes mellitus using real time ultrasonography. Am J Gastroenterol 91: 2391-2394, 1996."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Schvarcz E, Palm\u00e9r M, Ingberg CM, et al. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med 13: 478-481, 1996.","DOI":"10.1002\/(SICI)1096-9136(199605)13:5<478::AID-DIA104>3.0.CO;2-5"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Schiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology 99: 1772-1778, 1990.","DOI":"10.1016\/0016-5085(90)90486-K"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/22\/62_1405-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T03:21:49Z","timestamp":1700277709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/22\/62_1405-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":14,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1405-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"article-number":"1405-22"}}